{
    "2018-08-10": [
        [
            {
                "time": "",
                "original_text": "历经“阵痛”后医药股被治愈？医疗产业链个股全面爆发",
                "features": {
                    "keywords": [
                        "医药股",
                        "医疗产业链",
                        "全面爆发"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国家基本药物制度面临调整 优先调入通过一致性评价仿制药(附股)",
                "features": {
                    "keywords": [
                        "国家基本药物制度",
                        "一致性评价",
                        "仿制药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "仿制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}